Diabetes and Cancer: A consensus report

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

(2011) Alejandro Vazquez-Martin et al.   CELL CYCLE

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

(2011) Irina N. Alimova et al.   CELL CYCLE

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

(2011) Bolin Liu et al.   CELL CYCLE

Type 2 Diabetes: Assessing the Relative Risks and Benefits of Glucose-lowering Medications

(2010) Richard M. Bergenstal et al.   AMERICAN JOURNAL OF MEDICINE

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

(2010) Eek Joong Park et al.   CELL

Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, aurorasandpolo-like kinases] M-phase cell cycle genes in human breast cancer cells

(2010) Cristina Oliveras-Ferraros et al.   CELL CYCLE

Insulin analogues and cancer risk: cause for concern orcause célèbre?

(2010) M. Pollak et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?

(2010) Hertzel C. Gerstein   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis

(2009) Henry Buchwald et al.   AMERICAN JOURNAL OF MEDICINE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study

(2009) Jonathan L. Wright et al.   CANCER CAUSES & CONTROL

Is it Time to Test Metformin in Breast Cancer Clinical Trials?

(2009) M. Cazzaniga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue

(2009) R. C.M. van Kruijsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission

(2009) H. A. Hirsch et al.   CANCER RESEARCH

Expression and function of the insulin receptor substrate proteins in cancer

(2009) Katerina Mardilovich et al.   Cell Communication and Signaling

Do Cancer Cells Care If Their Host Is Hungry?

(2009) Michael Pollak   Cell Metabolism

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

(2009) Salvatore Ulisse et al.   CURRENT CANCER DRUG TARGETS

Insulin Glargine Controversy: A Tribute to the Editorial Team at Diabetologia

(2009) P. C. Butler   DIABETES

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

(2009) R. A. DeFronzo   DIABETES

Alcohol as a Risk Factor for Type 2 Diabetes: A systematic review and meta-analysis

(2009) D. O. Baliunas et al.   DIABETES CARE

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16

(2009) G. W.D. Landman et al.   DIABETES CARE

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

(2009) Doron Weinstein et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Prevention of gestational diabetes mellitus: a review of studies on weight management

(2009) Anne-Sophie Morisset et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

(2009) J. Rosenstock et al.   DIABETOLOGIA

The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings

(2009) C. J. Currie   DIABETOLOGIA

Does diabetes therapy influence the risk of cancer?

(2009) U. Smith et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines

(2009) Ashish Shukla et al.   ENDOCRINE-RELATED CANCER

Diabetes and cancer

(2009) Paolo Vigneri et al.   ENDOCRINE-RELATED CANCER

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

(2009) Sao Jiralerspong et al.   JOURNAL OF CLINICAL ONCOLOGY

Bariatric surgery, weight reduction, and cancer prevention

(2009) Andrew G Renehan   LANCET ONCOLOGY

A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish

(2009) Béatrice Secretan et al.   LANCET ONCOLOGY

Tumours with PI3K activation are resistant to dietary restriction

(2009) Nada Y. Kalaany et al.   NATURE

Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

(2009) J. Yun et al.   SCIENCE

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Sulphonylureas and cancer: a case–control study

(2008) Matteo Monami et al.   ACTA DIABETOLOGICA

Dietary Glycemic Index, Glycemic Load, and Risk of Cancer: A Prospective Cohort Study

(2008) S. M. George et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women’s Health Initiative

(2008) Geoffrey C. Kabat et al.   CANCER CAUSES & CONTROL

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

(2008) J. H. Law et al.   CANCER RESEARCH

Peroxisome Proliferator-Activated Receptor   Pathway Targeting in Carcinogenesis: Implications for Chemoprevention

(2008) F. Ondrey   CLINICAL CANCER RESEARCH

Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials

(2008) M. Monami et al.   DIABETES CARE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth

(2008) C. Algire et al.   ENDOCRINE-RELATED CANCER

Mitogenic Effect of the Insulin Analogue Glargine in Malignant Cells in Comparison with Insulin and IGF-I

(2008) E. Liefvendahl et al.   HORMONE AND METABOLIC RESEARCH

Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?

(2008) S Jabbour   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus

(2008) Bethany B. Barone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer

(2008) Brian M. Wolpin et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

(2008) Jing Ma et al.   LANCET ONCOLOGY

Insulin receptor expression by human prostate cancers

(2008) Michael E. Cox et al.   PROSTATE